{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 17,
        "end": 27
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 32,
        "end": 45
      }
    },
    {
      "id": "T3",
      "obj": "Disease",
      "span": {
        "begin": 50,
        "end": 78
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 95,
        "end": 101
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 17,
        "end": 45
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "20028383_1",
  "text": "Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1 * 28 polymorphism ."
}
